Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.
Sido
B
B
Department of Surgery, University of Heidelberg, Germany.
Morris
P J
PJ
Dallman
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000276:immunology* / Q000628:therapy; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016130:Immunophenotyping; D007376:Interleukin-2 / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D007958:Leukocyte Count / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D016572:Cyclosporine